Our magazine is free!

for living with diabetes

Articles related to "Novo Nordisk semaglutide" »

Novo Nordisk FDA submission for semaglutide

Friday, February 17th, 2017 | 0 Comments
Novo Nordisk Novo Nordisk has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) and a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for semaglutide, a new glucagon-like peptide-1 (GLP-1) analogue administered once-weekly, for the read more »